-
1
-
-
0024970402
-
Inhibition by reverse transcriptase activi-ty of a flavonoid compound, 5,6,7-trihydroxyflavone[J]
-
Ono K, Nakane H, Fukushima M, et al. Inhibition by reverse transcriptase activi-ty of a flavonoid compound, 5,6,7-trihydroxyflavone[J]. Biochem Biophys Res Commun, 1989,160(3):982.
-
(1989)
Biochem Biophys Res Commun
, vol.160
, Issue.3
, pp. 982
-
-
Ono, K.1
Nakane, H.2
Fukushima, M.3
-
2
-
-
0036046745
-
Biochanin A similarly influences the fluidity of liposomes formed from charged and zwitterionic lipids[J]
-
Hendrich A B, Zugaj J, Michalak K. Biochanin A similarly influences the fluidity of liposomes formed from charged and zwitterionic lipids[J]. Cell Mol Biol Lett, 2002,7(2):284.
-
(2002)
Cell Mol Biol Lett
, vol.7
, Issue.2
, pp. 284
-
-
Hendrich, A.B.1
Zugaj, J.2
Michalak, K.3
-
3
-
-
0034999671
-
Growth inhibition of human endothelial cells by the phytoestrogen biochanin A, a metabolite of genistein[J]
-
Ying C, Hsu J T, Shieh S C. Growth inhibition of human endothelial cells by the phytoestrogen biochanin A, a metabolite of genistein[J]. Br J Nutr, 2001,85(5):615-20.
-
(2001)
Br J Nutr
, vol.85
, Issue.5
, pp. 615-620
-
-
Ying, C.1
Hsu, J.T.2
Shieh, S.C.3
-
4
-
-
0030913875
-
Effects of biochanin A on the growth and differentiation of myeloid leukemia WEHI-3B (JCS) cells[J]
-
Fung M C, Szeto Y Y, Leung K N, et al. Effects of biochanin A on the growth and differentiation of myeloid leukemia WEHI-3B (JCS) cells[J]. Life Sci, 1997,61(2):105-15.
-
(1997)
Life Sci
, vol.61
, Issue.2
, pp. 105-115
-
-
Fung, M.C.1
Szeto, Y.Y.2
Leung, K.N.3
-
5
-
-
0036680526
-
Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts[J]
-
Rice L, Samedi V G, Medrano T A, et al. Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts[J]. Prostate, 2002,52(3):201-12.
-
(2002)
Prostate
, vol.52
, Issue.3
, pp. 201-212
-
-
Rice, L.1
Samedi, V.G.2
Medrano, T.A.3
-
6
-
-
0023687234
-
Rapid and automated tetrazoliumbased colorimetric assay for the detection of anti-HIV compounds[J]
-
Rudi P, Jan B, Masanori B, et al. Rapid and automated tetrazoliumbased colorimetric assay for the detection of anti-HIV compounds[J]. Virol Meth, 1988,20:309.
-
(1988)
Virol Meth
, vol.20
, pp. 309
-
-
Rudi, P.1
Jan, B.2
Masanori, B.3
-
7
-
-
0442309451
-
Tannin inhibits HIV-1 entry by targeting gp41[J]
-
Lu L, Liu S W, Jiang S B, et al. Tannin inhibits HIV-1 entry by targeting gp41[J]. Acta Pharmacol Sin, 2004,25(2):213-8.
-
(2004)
Acta Pharmacol Sin
, vol.25
, Issue.2
, pp. 213-218
-
-
Lu, L.1
Liu, S.W.2
Jiang, S.B.3
-
8
-
-
0029445163
-
Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals[J]
-
Rice W G, Bader J P. Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals[J]. Adv Pharmacol, 1995, 6:389-438.
-
(1995)
Adv Pharmacol
, vol.6
, pp. 389-438
-
-
Rice, W.G.1
Bader, J.P.2
-
9
-
-
1842502994
-
A fusion inhibitor for the treatment of HIV infection[J]
-
Fung H B, Guo Y. A fusion inhibitor for the treatment of HIV infection[J]. Criti Therap, 2004,26(3):352-78.
-
(2004)
Criti Therap
, vol.26
, Issue.3
, pp. 352-378
-
-
Fung, H.B.1
Guo, Y.2
-
10
-
-
29144505276
-
Addvancement in developing a new class of anti-AIDS drugs: HIV entry inhibitors[J]
-
Liu S W, Wu S G, Jiang S B, et al. Addvancement in developing a new class of anti-AIDS drugs: HIV entry inhibitors[J]. Chin Pharmacol Bull, 2005,21(9):1034-40.
-
(2005)
Chin Pharmacol Bull
, vol.21
, Issue.9
, pp. 1034-1040
-
-
Liu, S.W.1
Wu, S.G.2
Jiang, S.B.3
-
11
-
-
34247479957
-
New concepts in pathogenesis of HIV infection[J]
-
Zeng Y Y. New concepts in pathogenesis of HIV infection[J]. J Henan College Trad Chin Med, 2005,20(119):1-5.
-
(2005)
J Henan College Trad Chin Med
, vol.20
, Issue.119
, pp. 1-5
-
-
Zeng, Y.Y.1
-
12
-
-
0036192919
-
Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy[J]
-
Rizzardi G P, Harari A, Capiluppi B, et al. Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy[J]. J Clin Invest, 2002,109(5):681-8.
-
(2002)
J Clin Invest
, vol.109
, Issue.5
, pp. 681-688
-
-
Rizzardi, G.P.1
Harari, A.2
Capiluppi, B.3
|